Join the Society of Cannabis Clinicians for a special end-of-year webinar and festive social gathering—ugly Christmas sweaters encouraged. We’ll be unveiling our latest project, which tackles one of the biggest misunderstandings in modern medicine: Rooted in Evidence: Cannabis, Pharmaceuticals, and the Case for Reform. This session breaks down why botanical, whole-plant therapeutics fundamentally don’t fit...

About A Puff Before a Pour: Dose-Dependent Effects of Cannabis on Drinking Event Description: This month’s journal club will examine a landmark randomized controlled crossover trial exploring how smoked cannabis affects alcohol craving and consumption under controlled laboratory conditions. With the rise of THC beverages, “Cali sober” trends, and increasing co-use of cannabis and alcohol,...

About Welcome to our members-only monthly event series, CannaConnect Roundtable! This month is hosted by E.R.I.C. Cancer Playbook, powered by Whole Health Oncology Institute on the topic of patient-reported outcomes. Patient-reported outcomes (PROs)—what patients tell us about their symptoms, function, and quality of life—are transforming how we evaluate cancer care and integrative therapies, including medical...

About Psychedelic therapies are becoming more visible in both clinical research and public discourse, and patients often look to cannabis clinicians for trustworthy, evidence-based insights. While cannabis and psychedelics are distinct modalities, they share overlapping patient populations, therapeutic goals, and sociopolitical challenges. As these treatments gain momentum, clinicians must be prepared to discuss them responsibly,...

About Join us for an insightful presentation by Dr. Stacy D’Andre, a board‐certified oncologist at Mayo Clinic with a dedicated focus on integrative oncology, including the safe and evidence‐informed use...

About Speaker: Duncan Mackie, PhD, Director of Pharmacology & Experimental Therapeutics, MedPharm Holdings Event Description: Alzheimer’s disease remains one of the most challenging neurodegenerative conditions to treat, and interest is...